F869-1350 Screening compound: N-[(3-METHOXYPHENYL)METHYL]-1-(2-PHENYLPYRIMIDIN-4-YL)PIPERIDINE-4-CARBOXAMIDE

F869-1350 Screening compound: N-[(3-METHOXYPHENYL)METHYL]-1-(2-PHENYLPYRIMIDIN-4-YL)PIPERIDINE-4-CARBOXAMIDE
F869-1350 Screening compound: N-[(3-METHOXYPHENYL)METHYL]-1-(2-PHENYLPYRIMIDIN-4-YL)PIPERIDINE-4-CARBOXAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound F869-1350
N-[(3-METHOXYPHENYL)METHYL]-1-(2-PHENYLPYRIMIDIN-4-YL)PIPERIDINE-4-CARBOXAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F869-1350

Molecular Formula

C24H26N4O2 (C24 H26 N4 O2)

Compound Name

N-[(3-METHOXYPHENYL)METHYL]-1-(2-PHENYLPYRIMIDIN-4-YL)PIPERIDINE-4-CARBOXAMIDE

IUPAC name

n/a

SMILES

COc1cccc(CNC(C(CC2)CCN2c2nc(-c3ccccc3)ncc2)=O)c1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

402.5

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.784

Distribution Coefficient, logD

3.780

Water Solubility, LogSw

-3.91

Polar Surface Area

53.843

Acid Dissociation Constant (pKa)

13.07

Base Dissociation Constant (pKb)

5.36

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

29.20

F869-1350 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F869-1350 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F869-1350?
Check Price and Availability of F869-1350, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F869-1350 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F869-1350
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F869-1350
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F869-1350 available by request